|
Real-time Estimate
Cboe BZX
01:10:16 03/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 10.20 USD | +2.82% |
|
+3.10% | +29.94% |
| 25/08 | BioCryst Pharmaceuticals Announces Approval Of ORLADEYO For Pediatric HAE Patients In Japan | CI |
| 25/08 | BioCryst Pharmaceuticals Gets Japan Approval for Orladeyo in Young Children | MT |
Chart: Technical Analysis
Stock exchange
Nasdaq
BCRX 10.14 $
+2.17%
1.71Cr
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| BCRX | 10.14USD | +2.17% | 1.71Cr $ | |
CBOE
| BCRX | 10.20USD | +2.82% | 8L $ | |
|
Börse Stuttgart
| BO1 | 8.724EUR | +2.51% | 1L € | |
|
Deutsche Boerse AG
| BO1 | 8.788EUR | +6.21% | 13.18T € | |
|
Tradegate
| BO1 | 8.600EUR | +0.51% | 11.78T € | |
|
Mexican S.E.
| BCRX * | 182.00MXN | -6.67% | 18.2T $ | |
|
Boerse Muenchen
| BO1 | 8.716EUR | +2.32% | 0 € | |
|
Berne S.E.
| BO1 | 7.979CHF | +3.06% | 0 CHF |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 10.59 | 11.11 | 10.45 |
| Spread/Res. | -4.30% | -8.78% | -3.01% |
| Spread/Supp. | +15.04% | +23.75% | +23.30% |
| Support | 8.81 | 8.19 | 8.22 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- BCRX Stock
- Charts BioCryst Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
